|
|
|
Volumn 23, Issue 5 SUPPL. 10, 1996, Pages 48-54
|
|
Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer
a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ANTIEMETIC AGENT;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
CISPLATIN;
CREATININE;
GEMCITABINE;
HEMOGLOBIN;
LIVER ENZYME;
ADULT;
AGED;
BLOOD TOXICITY;
BONE MARROW TOXICITY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
THORAX RADIOGRAPHY;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
|
|
EID: 0029851532
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
